Eric Wittbrodt

Eric Wittbrodt

AstraZeneca, Sweden - Södertälje / Sweden
Medical and Health Sciences / Epidemiology and Public Health
AD Scientific Index ID: 4400849
-
person_outline Eric Wittbrodt's MOST POPULAR ARTICLES
1-) Low-dose oral naloxone reverses opioid-induced constipation and analgesia Journal of pain and symptom management 23 (1), 48-53, 2002
2-) Cardiovascular events associated with SGLT-2 inhibitors versus other glucose-lowering drugs: the CVD-REAL 2 studyM Kosiborod, CSP Lam, S Kohsaka, DJ Kim, A Karasik, J Shaw, N Tangri, ...Journal of the American College of Cardiology 71 (23), 2628-2639, 20183852018
3-) Kidney outcomes associated with use of SGLT2 inhibitors in real-world clinical practice (CVD-REAL 3): a multinational observational cohort studyHJL Heerspink, A Karasik, M Thuresson, C Melzer-Cohen, G Chodick, ...The lancet Diabetes & endocrinology 8 (1), 27-35, 20202462020
4-) Low-dose oral naloxone reverses opioid-induced constipation and analgesiaM Liu, E WittbrodtJournal of pain and symptom management 23 (1), 48-53, 20022582002
5-) Burden of chronic kidney disease by KDIGO categories of glomerular filtration rate and albuminuria: a systematic reviewM Murton, D Goff-Leggett, A Bobrowska, JJ Garcia Sanchez, G James, ...Advances in therapy 38, 180-200, 20211822021